ArticlePharmaceutics2022

A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer.

Kyemyung Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.